|
|
A Genome Wide RNAi Vulnerability Map for Myeloma
|
5R01CA133115-02
|
$254,717
|
$254,717
|
STEWART, ALEXANDER
|
MAYO CLINIC COLL OF MED, MAYO CLINIC AZ
|
|
|
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1
|
ZIA BC 011064
|
$247,815
|
$198,252
|
Mock, Beverly
|
CCR (NCI)
|
|
|
A Novel Antibody Therapeutic for Multiple Myeloma
|
5R44CA105840-03
|
$466,655
|
$466,655
|
CHINTALACHARUVU, KOTESWARA
|
CHIMERIC TECHNOLOGIES, INC.
|
|
|
Adenosine Analogs: Therapeutics for Hematologic Cancers
|
5R01CA085915-09
|
$311,259
|
$155,630
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
Adult Leukemia Research Center
|
5P01CA018029-34
|
$5,273,382
|
$105,468
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
An anti-CD74 MAb-drug conjugate for B-cell malignancies
|
5R44CA108083-03
|
$309,824
|
$309,824
|
GOVINDAN, SERENGULAM
|
IMMUNOMEDICS, INC.
|
|
|
Animal Model and Genotyping Core Support Facility
|
ZIC BC 011047
|
$943,811
|
$283,143
|
DuBois, Wendy
|
CCR (NCI)
|
|
|
Anti-beta2 microglobulin mAbs as a novel therapeutic agent in multiple myeloma
|
1K99CA137158-01A1
|
$84,240
|
$84,240
|
YANG, JING
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Anti-TfR IgG3-Av: A New Drug Against Multiple Myeloma
|
5R01CA107023-05
|
$300,313
|
$300,313
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Antibody Neutralization of Therapeutic Viruses
|
5R01CA129966-02
|
$500,247
|
$500,247
|
RUSSELL, STEPHEN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
Arsenic-induced apoptosis in myeloma
|
1R01CA129968-01A2
|
$383,922
|
$383,922
|
BOISE, LAWRENCE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
Atlanta Regional Community Clinical Oncology Program (ARCCOP)
|
5U10CA045450-23
|
$709,605
|
$7,096
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
$10,424
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-08
|
$749,588
|
$7,496
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
|
Biology of Multiple Myeloma Stem Cells
|
5K23CA107040-05
|
$138,510
|
$138,510
|
MATSUI, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Bone Marrow Grafting for Leukemia and Lymphoma
|
5P01CA049605-21
|
$3,525,298
|
$387,783
|
NEGRIN, ROBERT
|
STANFORD UNIVERSITY
|
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-34
|
$3,012,562
|
$753,141
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Bone-seeking proteasome inhibitors for myeloma
|
5K01CA113468-05
|
$153,226
|
$76,613
|
AGYIN, JOSEPH
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
|
Branch Clinical Research Core
|
ZID BC 010963
|
$1,239,800
|
$123,980
|
Gress, Ronald
|
CCR (NCI)
|
|
|
Breast implant follow-up study
|
ZIA CP010128-01220
|
$16,802
|
$840
|
Brinton
|
DCEG (NCI)
|
|
|
CALGB Member Site: University of California - San Francisco
|
1U10CA138561-01
|
$107,184
|
$18,221
|
RYAN, CHARLES
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Canadian Contribution to NCI Intergroup Program
|
5U10CA077202-12
|
$1,344,388
|
$188,214
|
Meyer, Ralph
|
QUEEN'S UNIVERSITY AT KINGSTON
|
|
|
Cancer and Leukemia Group B
|
2U10CA032291-28
|
$413,820
|
$70,349
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Cancer and Leukemia Group B
|
2U10CA047577-22
|
$157,170
|
$26,719
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
|
Cancer and Leukemia Group B
|
2U10CA077597-12
|
$65,608
|
$11,153
|
LIU, MINETTA
|
GEORGETOWN UNIVERSITY
|
|
|
Cancer and Leukemia Group B
|
2U10CA077651-12
|
$213,953
|
$36,372
|
HUDIS, CLIFFORD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Cancer and Leukemia Group B
|
2U10CA041287-24
|
$323,700
|
$55,029
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
|
Cancer and Leukemia Group B
|
2U10CA031946-28
|
$11,457,918
|
$1,947,846
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
|
Cancer and Leukemia Group B
|
3U10CA037447-25S1
|
$1,710,507
|
$153,946
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
|
Cancer and Leukemia Group B
|
2U10CA047559-19
|
$140,454
|
$23,877
|
SHEA, THOMAS
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
Cancer and Leukemia Group B - Leukemia Correlative Sciences
|
2U10CA101140-07
|
$861,611
|
$146,474
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
|
Cancer and Leukemia Group B - The Ohio State University
|
2U10CA077658-12
|
$494,501
|
$84,065
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
|
Cancer and Leukemia Group B Statistical Center
|
2U10CA033601-30
|
$4,929,147
|
$837,955
|
GEORGE, STEPHEN
|
DUKE UNIVERSITY
|
|
|
Cancer and Leukemia Group B: RPCI/SUNYAB
|
2U10CA059518-17
|
$229,395
|
$38,997
|
LEVINE, ELLIS
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-34S1
|
$113,210
|
$3,396
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-34S2
|
$124,410
|
$3,732
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-34S3
|
$99,940
|
$2,998
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Cancer Center Support (Core) Grant
|
5P30CA016672-34
|
$10,451,830
|
$313,555
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$116,889
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Cancer Center Support Grant
|
2P30CA023108-31
|
$3,290,263
|
$164,513
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
|
Cancer Center Support Grant
|
3P30CA023108-31S2
|
$87,459
|
$4,373
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA086862-10S1
|
$83,430
|
$15,852
|
WEINER, GEORGE
|
UNIVERSITY OF IOWA
|
|
|
Cancer Center Support Grant (CCSG)
|
5P30CA086862-10
|
$2,209,426
|
$419,791
|
WEINER, GEORGE
|
UNIVERSITY OF IOWA
|
|
|
Cancer Risk and Environmental Exposures
|
ZIA CP010120-02135
|
$102,894
|
$9,260
|
Cantor, Kenneth
|
DCEG (NCI)
|
|
|
Cancer risk in x-ray technologists
|
ZIA CP010133-04180
|
$1,340,943
|
$26,819
|
Linet
|
DCEG (NCI)
|
|
|
Cancer Stem Cell Targeting in Multiple Myeloma
|
5R01CA127574-02
|
$272,240
|
$272,240
|
MATSUI, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-26
|
$841,092
|
$8,411
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Total relevant funding to Multiple Myeloma for this search: $45,183,304
|
